HER2-low
About
Biomarker Type: Protein expression
Present: True
Marker: Human epidermal growth factor receptor 2 (HER2)
Unit: status
Equality: =
Value: Low
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| EMA (1) FDA (1) | HER2-low | Invasive Breast Carcinoma | Trastuzumab deruxtecan | |
| EMA (1) | ER positive, HER2-low | Invasive Breast Carcinoma | Trastuzumab deruxtecan | |
| EMA (1) | HER2-low, PR positive | Invasive Breast Carcinoma | Trastuzumab deruxtecan | |
| EMA (1) | ER positive, HER2-low, PR positive | Invasive Breast Carcinoma | Trastuzumab deruxtecan |